| |
| | Recombinant growth hormone therapy for X-linked hypophosphatemia in children (Cochrane Review) (Site not responding. Last check: 2007-11-06) |
 | | Conventional treatment of X-linked hypophosphatemia with oral phosphate and calcitriol can heal rickets, but it does not always raise serum phosphate concentrations significantly, nor does it always normalize linear growth. |
 | | To determine whether recombinant human growth hormone therapy for children with X-linked hypophosphatemia is associated with changes in longitudinal growth, mineral metabolism, endocrine function, renal function, bone mineral density, body proportions, and also with any adverse effects. |
 | | We have found no conclusive evidence to indicate that the use of recombinant human growth hormone therapy in children with X-linked hypophosphatemia is associated with changes in longitudinal growth, mineral metabolism, endocrine, renal function, bone mineral density, and body proportions. |
| www.update-software.com /Abstracts/AB004447.htm (509 words) |
|